Welcome to the DermaSensor Newsroom. Here, you'll find the latest articles from skin-evaluation experts, discover emerging technology entering the market, and learn how general practitioners are adopting faster, easier, smarter tools to improve clinical decision making for their patients. See what the future standard of skin evaluation looks like, from Melbourne to Miami.
I am honored for DermaSensor Inc. to be selected as winner of the #medtechinnovator Mid-Stage Pitch Competition and to join Paul Grand in their 2022 cohort.
A big thanks to Chris Newmarker from MassDevice for this article about the competition and for the kind words about our work!
lnkd.in/ev2ZKFJH
#healthtech #healthcareinnovation #skincancerawarenessmonth #pointofcare #digitalhealth #aihealthcare #primarycare #dermatology
We are honored that the American Academy of Dermatology published the results of our melanoma clinical validation study at their conference this week, DERM-ASSESS III, and provided the study Principal Investigator, Dr. Rebecca Hartman from the Dana-Farber Cancer Institute and Harvard Medical School, with an opportunity to share the results as a late-breaking podium presentation. The study results of 96% sensitivity for melanoma detection and 98% Negative Predictive Value further add to the clinical validation and clinical utility evidence behind our technology.
www.einnews.com/pr_news/566803639/dermasensor-inc-announces-positive-results-from-melanoma-clinic...
#skincancerprevention #melanomaawareness #medicaldevices #healthtechnology
It's almost here! This week on December 8th and 9th Dermasensor, along with over 40 other startups, will be discussing what comes next for AI, pharma, and everything in between.
The future of healthcare effects everyone. You don't want to miss this virtual conference, so register now to snag your spot: ow.ly/LRO850H4nqH
Recently our CEO Cody Simmons was featured on Health Podcast Network to share how Dermasensor is on the front lines of the fight against skin cancer.
Learn more about how we are equipping GPs to better detect melanoma here: ow.ly/GrNn50G5SlB
It's important for your patients to stay current with their screenings. In a recent study, patients with a family history of melanoma were shown to have better outcomes and earlier detection with routine screenings.
Read more on the study findings here: ow.ly/Saku50FAENd
#melanoma #earlydetection
Exciting things are happening in the fight against melanoma! Researchers at Boston University School of Medicine have recently discovered that a cancer fighting drug can be used more broadly than previously thought.
Read more here about the advances in fighting this aggressive cancer:
www.sciencedaily.com/releases/2021/02/210201115937.htm
#melanoma #earlydetection
Thank you Medtechdive and Nick Paul Taylor for profiling our fast-growing company and promising new technology. We're honored to share the spotlight with other featured products and trust many patients will benefit from this forward-looking FDA program.
Non-invasive, low-cost and easy-to-use technologies as well as machine learning are increasingly important in the war against cancer. With our recent FDA breakthrough designation, DermaSensor is one step closer to equipping US doctors with our novel skin cancer detection tool.
lnkd.in/dkw7DsH
#fda #healthcare #medicalsciences #medicine #cancertreatment #cancerdetection #digitalhealth #aihealthcare #primarycare #dermatology #technology
A vaccine that protects against cancer sounds like science fiction. But results posted in Nature Medicine suggest that personalized vaccines have been shown to be effective within a recent study group.
Learn more here about these incredibly findings here:
www.sciencedaily.com/releases/2021/01/210121131857.htm
#cancer #research #vaccine
MIAMI, FLORIDA, UNITED STATES, June 15, 2022 /EINPresswire.com/ Miami-Based DermaSensor, Inc. Raises Additional $10 Million To Prepare for U.S. Launch DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians (PCPs) …
